The research team is now monitoring 12 more participants who received higher doses of 150,000 and 250,000 cells. If no safety ...
A new approach pioneered by Aalto University scientists uses controlled warmth to trigger self-repair within retinal cells ...
A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show ...
The overall dry AMD market size in the US is anticipated to increase, due to the uptake of recently approved therapies, the launch of emerging therapies such as Gildeuretinol (Alkeus Pharmaceuticals), ...
Aalto University scientists have created a laser-based treatment that uses gentle heat to stop the progression of dry macular ...
A laser treatment for this common eye disease will start clinical trials in Finland next spring ––researchers hope it could be available to sufferers in as little as three years Around a third of ...
ANNX advances tanruprubart for Guillain-Barré syndrome, with an EMA filing planned for January 2026 and ongoing FDA ...
In a first-in-human phase 1/2a clinical trial, researchers used adult stem cells to help restore vision in people with age-related macular degeneration. In the United States, age-related macular degen ...
Medpage Today on MSN
Wet AMD: Tips on Navigating Anti-VEGF Drug Options
According to Liu, his preferred option is faricimab, a fairly new agent that was FDA-approved for wet AMD in 2022. The drug ...
The FDA approved Eylea HD for the treatment of macular edema following retinal vein occlusion, according to a press ...
In this video from the American Academy of Ophthalmology meeting, Esther M. Bowie, MD, discusses what is “new and exciting” in wet age-related macular degeneration.Tyrosine kinase inhibitors being ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback